Tanaka Yusuke, Nakashima Yuri, Mima Toru, Ohya Masaki, Yamamoto Shuto, Kobayashi Sou, Masumoto Asuka, Masumoto Koji, Yano Takurou, Moribata Mari, Yoshimoto Wataru, Yamanaka Shintaro, Koreeda Daisuke, Hanba Yoshiyuki, Tatsuta Koichi, Sakaguchi Toshifumi, Negi Shigeo, Shigematsu Takashi
Department of Nephrology and Dialysis, Shingu Municipal Medical Center, Japan.
Intern Med. 2015;54(17):2207-11. doi: 10.2169/internalmedicine.54.4330. Epub 2015 Sep 1.
A 29-year-old woman was diagnosed with Henoch-Schönlein purpura nephritis (HSPN) based on the presence of purpura and histopathological findings showing crescent formation, mesangial proliferation and IgA deposition in the glomerular mesangium. She was treated with high-dose steroids; however, the nephritic syndrome persisted. Therefore, we diagnosed her with steroid-resistant HSPN and decided to add treatment with cyclosphamide pulse therapy. After one year of treatment, the histopathological findings, including crescent formation and IgA deposition, improved, as confirmed on a renal biopsy, and the patient fulfilled the criteria for complete remission. Cyclophosphamide pulse therapy may be considered an effective treatment for intractable HSPN.
一名29岁女性因出现紫癜以及组织病理学检查结果显示有新月体形成、系膜增生和IgA在肾小球系膜沉积而被诊断为过敏性紫癜性肾炎(HSPN)。她接受了大剂量类固醇治疗;然而,肾病综合征持续存在。因此,我们诊断她为类固醇抵抗性HSPN,并决定加用环磷酰胺脉冲疗法进行治疗。经过一年的治疗,肾活检证实包括新月体形成和IgA沉积在内的组织病理学检查结果有所改善,且该患者符合完全缓解的标准。环磷酰胺脉冲疗法可被认为是治疗难治性HSPN的一种有效疗法。